Hefe, die Bakterie Bacillus subtilis, die Pflanze Arabidopsis thaliana, die Maus… und dann der Mensch. Das Abenteuer der Sequenzierung hat gerade erst begonnen, und die Biowissenschaften treten in das Zeitalter der Genomik ein.

Die „kulturelle Revolution“ unternehmerischer Wissenschaftler.

Der Aufschwung des Risikokapitals und die Entwicklung neuer Börsenmärkte eröffnen jungen europäischen Hightech-Unternehmen interessante Aussichten.

Rekordwachstum für die Biotechnologie.

Der Aktionsplan Biowissenschaften und Biotechnologie.

Begegnung mit Gerard ‘t Hooft, Nobelpreisträger für Physik 1999.

Ein Gespräch mit Giorgio Israel (Universität La Sapienza, Rom), Mathematiker und spezialisiert auf die Geschichte dieser Disziplin, Humanist und Philosoph, macht sich Gedanken über das Abdriften der Technowissenschaften, den Missbrauch der Mathematik und die Grundlagen einer neuen Rationalität.

Maxim Kontsewitsch, 1998 mit der Fields-Medaille, dem „Nobelpreis" für Mathematik, ausgezeichnet, ist einer der brillanten russischen Wissenschaftler, die nach dem Zusammenbruch der ehemaligen Sowjetunion in den Westen gingen. Der Weg eines „großeuropäischen" Denkers, der sich zum Bleiben entschloss.

Die unten stehenden Zusammenfassungen werden nur auf Englisch präsentiert, während die meisten Artikel in mehreren Sprachen verfügbar sind.

Um auf diese zuzugreifen, klicken Sie zunächst auf die englische Version und kehren zum Inhalt zurück, indem Sie auf die Nummer der Zeitschrift klicken. Auf der Seite "Inhalt" können Sie dann unter den angebotenen Sprachen Ihre Wahl treffen.

If neurons die, then why not replace them? This is simple idea which proved remarkably effective when transplanting foetal neurons to sufferers from Parkinson's disease. Research is now turning its attention to finding new sources of neurons for transplantation, thereby making the treatment as widely available as possible.
 

The full sequencing of the human genome is being completed - spectacularly - 15 years ahead of the initial target date. An example of the formidable increase in the speed of modern genome research - due to the partnership between basic science and the computer - and of the fierce competition between public and private research which helped generate the momentum. This is a competition which also lies at the heart of the ethical debate on the 'ownership' of mankind's genetic heritage.
 

At the same time as participating very actively in the international Human Genome Project, Europe has also been developing its expertise in all areas of genomic research into the living world. Over the past decade, European research programmes have supported many projects that have resulted in some spectacular 'firsts' - such as the sequencing of organisms including yeast, the bacteria Bacillus subtilis or the plant Arabidopsis thaliana.
 

A strange frontier divides automation into two fields. On the one hand you have the engineers in South-East Asia who swear by "fuzzy" control. On the other, the European and US champions of automated systems based on traditional linear control. The Famimo project sets aside any such partisanship and puts the industrial promise of "fuzzy" systems to the test.
 

European scientists and industrialists working on the Plasmatex project are on the point of demonstrating the feasibility of a technology of the future: textile processing using plasmas at atmospheric pressure. This development meets new needs in a sector where Europe is still very active.
 

New ellipsometer designs to assess metal surface properties.
 

The microelectronics industry's race for miniaturisation is fast approaching the realm of nanotechnology. A new, more multidisciplinary paradigm is required, with major implications for fields as diverse as microelectronics, quantum physics and biology.
 

NANOWIRES project has developed key insights into the behaviour of molecule-sized wires in integrated circuits.
 

The research team which demonstrated quantum teleportation late last year was brought together through the Training and Mobility of Researchers (TMR) Programme. RTD Info met Anton Zeilinger, leader of both research group and TMR network, to see how this and other EC programmes are helping keep European talent in Europe.
 

The JRC has a number of experimental facilities which are unique in Europe, devoted to developments at the very highest level. In this article we take a closer look at the Petten reactor and the Ispra cyclotron, two installations whose applications relate in particular to the latest developments in nuclear medicine.